Ömer Şentürk

Role of Ursodeoxycholic Acid in Prevention of Methotrexate-induced Liver Toxicity

Süleyman Uraz, Veysel Tahan, Cem Aygün et al. · Digestive Diseases and Sciences · 2007 · 133 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Association of Apolipoprotein E Polymorphisms in Patients with Non-Alcoholic Steatohepatitis

Gürler Akpınar, Cem Aygün, Emel Ergül et al. · Digestive Diseases and Sciences · 2008 · 77 citations

Medicine, Genetics, Molecular Genetics +14

Evaluation of Metabolic Syndrome Frequency and Carotid Artery Intima-media Thickness as Risk Factors for Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease

Cem Aygün, Orhan Kocaman, Süleyman Uraz et al. · Digestive Diseases and Sciences · 2007 · 69 citations

Medicine, Cardiology, Internal Medicine +15

Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease

Cem Aygün, Ömer Şentürk, Saadettin Hülagü et al. · European Journal of Gastroenterology & Hepatology · 2006 · 57 citations

Medicine, Biochemistry, Pathology +12